KNOWLEDGE BANK

Interviews

Digital Transformation in Pharma Manufacturing | David Holt, FactoryTalk | ISPE 2026 | Pharma Focus Asia

Group Executive Director, FactoryTalk
David Holt is the Group Managing Director at Factory Talk with extensive leadership experience across multiple industries He focuses on innovative software solutions that enable the digital transformation of operations within GxP pharmaceutical and medical deviceregulated industries

Articles

The Therapeutics Landscape of Miniproteins

marks years since the approval of the first monoclonal antibody mAb muromononabCD OKT in Over four decades the pharmaceutical industry has accumulated an extraordinary body of knowledge on how to discover engineer manufacture and safely administer antibodybased therapeutics

Research Insights

Evaluation of retail pharmacists' perception on patient safety

Patient safety has become a focus of clinical care and research in recent years However the potential for medical care to cause harm has been appreciated throughout the history of medicine The safety culture of an organization is the product of individual and group values attitudes perceptions competencies and patterns of behavior that determine the commitment to and the style and proficiency of an organ

Case Studies

Regulating Pharmaceutical Industry Marketing: Development, Enforcement And Outcome Of Marketing Rules: A Case Study By Lund University

Abstract This essay studies work in sociology and cognate fields regarding pharmaceutical marketing and its regulation In particular it considers how this literature contributes to a better understanding of the process of pharmaceuticalization defined as the translation or transformation of human conditions capabilities and capacities into opportuni

Techno Trends

Singapore Launches New Initiative to Boost Biopharmaceutical Innovation

Singapore government announces a new initiative aimed at enhancing biopharmaceutical innovation in the region

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Advanced Nanobots for ‘Programmed’ Biomedical Applications

Amaresh Kumar Sahoo

Assistant Professor, Department of Applied Sciences, Indian Institute of Information Technology

Saurabh Shivalkar

Research Fellow, Department of Applied Sciences, Indian Institute of Information Technology

2

Changing Paradigms in Use of AI in Chemical Sciences

Prashant S. Kharkar

Prashant S. Kharkar, a well-respected Drug Discovery Researcher with rich industrial experience, received his B. Pharm. degree in 1998. He obtained his PG and Ph.D. (Tech.) degrees Institute of Chemical Technology (ICT), Mumbai, India. Dr. Kharkar completed his postdoctoral research (2006–2009) on neurodegenerative diseases and disorders.

Akash S. Sirsat

Akash Sirsat is pursuing M.Tech in Pharmaceutical Chemistry and Technology at the Institute of Chemical Technology (ICT), Mumbai. He completed his Bachelor of Pharmacy from Sinhgad Institute’s SKNCOP, Pune. His research interests include pharmaceutical chemistry, process development, and applications of AI/ML in pharmaceutical synthesis. He has qualified GPAT, GATE, NIPER, and GAT-B.

3

Nanotechnology Strategies for Age –Related Macular Degeneration

Aira Sarkar

Aira Sarkar is pursuing B. Tech (Pharmaceutical Chemistry and Technology) in Department of Pharmaceutical Science and Technology, Institute of Chemical Technology (ICT).

 

Sathish Dyawanapelly

Sathish Dyawanapelly is working as an Assistant Professor in Department of Pharmaceutical Science and Technology, Institute of Chemical Technology (ICT).

 

4

Artificial Intelligence in Oncology

Nancy Kapila

Nancy Kapila is a seasoned pharmaceutical consultant with over 5 years of varied experience and a Master’s in Pharmaceutics from Panjab University. She excels in drug mechanisms and interactions. Her career highlights include collaborating with numerous pharmaceutical companies and offering strategic insights and guidance. Nancy stands out for her dedication to keeping abreast of pharmaceutical advancements, regulatory changes, and emerging trends. She believes in continuous learning to navigate the industry’s complexities and provide innovative client solutions. Fascinated by the role of data analytics in decision-making, Nancy delves into data to uncover patterns and opportunities, offering evidence-based recommendations for process optimization, product development, and operational efficiency. Her career is driven by a relentless pursuit of knowledge, passion for data insights, and commitment to leading pharmaceutical companies towards success in a dynamic industry.

 

5

Nanomedicine

Vinoth-Kumar Lakshmanan

Vinoth-Kumar Lakshmanan is a Senior Investigator and Professor for Prostate Cancer Biomarker Laboratory, Faculty of Clinical Research at Sri Ramachandra Institute of Higher Education and Research (DU), India and Adjunct Professor of Faculty of Engineering and Architectural Science, Toronto Metropolitan University, Canada. Vinoth has 20+ years’ experience in cancer biology. Scientific H Index 33 achieved with 4500 plus citations. He obtained Ph.D from University of Strasbourg, France, Post Doctoral from University of Regensburg and Karlsruhe Institute of Technology (KIT), Germany.

press releasesRead more...

Innovent Biologics announced a strategic collaboration with Eli Lilly on research and development and licensing.

Innovent Biologics SSE HKSE a hightech biopharmaceutical company today announced a strategic collaboration agreement with Eli Lilly and Company for research and licensing focusing on the development of innovative drugs

Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle® Platform

Cellares the first Integrated Development and Manufacturing Organization IDMO and Seoul National University Hospital SNUH a leading translational medical center in South Korea today announced a partnership

Zymeworks Completes Acquisition of Theravance Biopharma

Zymeworks Inc Nasdaq ZYME a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel multifunctional biotherapeutics today completed

UofG announces second research collaboration with Eli Lilly and Company for immune-related diseases

Worldchanging experts at the University of Glasgow will partner with scientists at leading pharmaceutical company Eli Lilly and Company Lilly to tackle immunerelated diseases

Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development

Thermo Fisher Scientific the world leader in serving science today announced the Gibco CHOK Catalog Panel a cGMPready portfolio of basal and feed media designed to support strong

Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services

Oracle Life Sciences announced a partnership with Wipro Limited a leading AIpowered technology services and consulting company to strengthen Wipros pharmacovigilance PV service offering using Oracle Life

EventsRead more...

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

29 - 01

Sep 2026

Powtech Technopharm 2026

Nuremberg, Germany

30 - 01

Sep 2026

Pharma Launch Excellence Summit

Hyatt Regency Boston Harbor, B...

01 - 01

Oct 2026

05 - 06

Oct 2026

ISPSAI France 2026

Paris, France

05 - 08

Oct 2026

12 - 13

Oct 2026

Pharmaceutics 2026

Village Hotel Changi, Singapor...

LATEST NEWSRead more...

Turbine and Daiichi Sankyo Expand ADC Discovery Collaboration

Turbine and Daiichi Sankyo have expanded their collaboration to support antibodydrug conjugate ADC discovery using computational modelling

TriSalus Receives FDA Clearance for TriNav Advance for Liver Embolisation

TriSalus Life Sciences has received k clearance from the US Food and Drug Administration FDA for TriNav Advance a new device within its PressureEnabled Drug Delivery PEDD portfolio for liverdirected embolisation procedures

SK pharmteco and GEMMABio Expand Manufacturing Collaboration for SMA Gene Therapy

SK pharmteco and Gemma Biotherapeutics GEMMABio have expanded their manufacturing collaboration to support the clinical development of GB an investigational gene therapy for spinal muscular atrophy type SMA

Merck’s KEYTRUDA QLEX Approved for Subcutaneous Administration

Merck has announced that Japans Ministry of Health Labour and Welfare MHLW has approved KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfapmph for subcutaneous administration

Dualitas Therapeutics and Roche Partner to Discover Bispecific Antibodies for I&I Diseases

Dualitas Therapeutics has announced a research collaboration and licence agreement with Roche to discover and develop novel bispecific antibody BsAb therapies for immunology and inflammation II diseases

Eisai and Biogen Receive Approval for LEQEMBI Pen for Early Alzheimer’s Disease

Eisai and Biogen have received approval in Japan for LEQEMBI Pen a subcutaneous SC formulation of lecanemab for the treatment of early Alzheimers disease AD